Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The formulation pairs a stabilized GHRH receptor agonist with a selective growth hormone secretagogue receptor (GHS-R) agonist, allowing concurrent investigation of GHRH and ghrelin / GHS pathway activation
FOXO4-DRI Based on 1 publication(s) in Google Scholar FOXO4-DRI is a cell-permeable peptide antagonist that blocks the interaction of FOXO4 and p53
The most common reported issue is mild irritation at the injection site
Supports Anti-Aging Combats signs of aging with powerful antioxidants
US$ 29.39
US$ 25.00
US$ 29.13
US$ 26.17
